1333 FG-3165 is a novel galectin-9 neutralizing antibody that inhibits galectin-9-mediated dimerization of TIM-3 and galectin-9-induced apoptosis of CD4+ and CD8+ T cells

• John Hunter,
• Prachi Bagadia,
• Selene Li,
• Mitch Brenner,
• Veronica Rodriguez,
• Mark Sternlicht,
• Todd Seeley,
• Dave Olsen,
• Gail Walkinshaw

Affiliations

John Hunter

1 Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA

Prachi Bagadia

Aff1 grid.48336.3a0000000419368075Surgery BranchNCI/NIH Bethesda MD USA

Selene Li

FibrGen, San Francisco, CA, USA

Mitch Brenner

FibrGen, San Francisco, CA, USA

Veronica Rodriguez

FibrGen, San Francisco, CA, USA

Mark Sternlicht

FibrGen, San Francisco, CA, USA

Todd Seeley

FibrGen, San Francisco, CA, USA

Dave Olsen

FibrGen, San Francisco, CA, USA

Gail Walkinshaw

FibrGen, San Francisco, CA, USA